Evidence map›Paper›PMID 24291635›Full record

ArticleMolecular and cellular endocrinology2014

Hypo-glycosylated human follicle-stimulating hormone (hFSH(21/18)) is much more active in vitro than fully-glycosylated hFSH (hFSH(24)).

George R Bousfield, Vladimir Y Butnev, Viktor Y Butnev, Yasuaki Hiromasa, David J Harvey, Jeffrey V May

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Molecular and cellular endocrinology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03868202 (Follicle Stimulating Hormone), which is not on this map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
7.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03868202 phase2unknown statusnot on this mapstarted 2019, after this paper: background citation

Follicle Stimulating Hormone (FSH) Glycosylation in Women: Effect of Estradiol

TypeinterventionalSponsorEastern Virginia Medical SchoolRan2019 to 2020Enrolled10ConditionsFollicle Stimulating Hormone Glycosylation, Urinary FSH21/FSH24 Ratio, Estradiol EffectArmsEstradiol Transdermal Product
3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Human FSH Glycoform α-Subunit AsparagineFrontiers in endocrinology · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

George R BousfieldDepartment of Biological Sciences, Wichita State University, Wichita, KS 67260-0026, USA. Electronic address: george.bousfield@wichita.edu.
Vladimir Y ButnevDepartment of Biological Sciences, Wichita State University, Wichita, KS 67260-0026, USA.
Viktor Y ButnevDepartment of Biological Sciences, Wichita State University, Wichita, KS 67260-0026, USA.
Yasuaki HiromasaBiotechnology Core Facility, Kansas State University, Manhattan, KS 66506, USA.
David J HarveyDepartment of Biochemistry, University of Oxford, South Parks Road, Oxford 0X1 3QU, UK.
Jeffrey V MayDepartment of Biological Sciences, Wichita State University, Wichita, KS 67260-0026, USA.
Wichita State University · USKansas State University · USUniversity of Oxford · GB

Funding

UNDERSTANDING THE ROLE OF SMALL RNAS IN ARABIDOPSIS POLLEN DEVELOPMENTP20RR016475 · NCRR · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ACKLEY, BRIAN DOUGLAS · 2001 to 2011
$38.1M
The Aging Pituitary/Gonadal AxisP01AG029531 · NIA · WICHITA STATE UNIVERSITY · PI GEORGE R BOUSFIELD · 2009 to 2026
$25.9M
Wichita State University Combined Core Facility Renovation projectG20RR031092 · NCRR · WICHITA STATE UNIVERSITY · PI HENDRY, WILLIAM J · 2010 to 2010
$2.2M
NCRR NIH HHS G20 RR-031092NCRR NIH HHS G20 RR031092NCRR NIH HHS P20 RR-016475NCRR NIH HHS P20 RR016475NIA NIH HHS P01 AG-029531NIA NIH HHS P01 AG029531
6 · The paper itself

Abstract

Hypo-glycosylated hFSH(21/18) (possesses FSHβ(21) and FSHβ(18)bands) was isolated from hLH preparations by immunoaffinity chromatography followed by gel filtration. Fully-glycosylated hFSH(24) was prepared by combining the fully-glycosylated FSHβ(24) variant with hCGα and isolating the heterodimer. The hFSH(21/18) glycoform preparation was significantly smaller than the hFSH(24) preparation and possessed 60% oligomannose glycans, which is unusual for hFSH. Hypo-glycosylated hFSH(21/18) was 9- to 26-fold more active than fully-glycosylated hFSH(24) in FSH radioligand assays. Significantly greater binding of (125)I-hFSH(21/18) tracer than hFSH(24) tracer was observed in all competitive binding assays. In addition, higher binding of hFSH(21/18) was noted in association and saturation binding assays, in which twice as much hFSH(21/18) was bound as hFSH(24). This suggests that more ligand binding sites are available to hFSH(21/18) in FSHR than to hFSH(24). Hypo-glycosylated hFSH(21/18) also bound rat FSHRs more rapidly, exhibiting almost no lag in binding, whereas hFSH(24) specific binding proceeded very slowly for almost the first hour of incubation.

Indexed as

AnimalsBinding, CompetitiveBinding SitesChromatography, AffinityChromatography, GelFollicle Stimulating Hormone, HumanGlycoprotein Hormones, alpha SubunitGlycosylationHumansIodine RadioisotopesLuteinizing HormoneMannoseProtein BindingProtein MultimerizationRadioligand AssayRatsFollicle Stimulating Hormone, HumanGlycoprotein Hormones, alpha SubunitIodine RadioisotopesLuteinizing HormoneMannoseReceptors, FSHFSH isoformsFSHROligosaccharide

Identifiers

PMID24291635
PMCPMC3908837
OpenAlexW2093876574

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.